Literature DB >> 23463875

Reply to MacLeod et al.: Multiple myeloma plasma cells have chameleon characteristics.

Susanne B Breitkopf, Min Yuan, German A Pihan, John M Asara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23463875      PMCID： PMC3557032          DOI： 10.1073/pnas.1220582110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Multiple myeloma preceding the development of chronic myelogenous leukemia.

Authors:  M Nitta; K Tsuboi; S Yamashita; M Kato; Y Hayami; S Harada; H Komatsu; S Iida; S Banno; A Wakita; R Ueda
Journal:  Int J Hematol       Date:  1999-04       Impact factor: 2.490

2.  P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma.

Authors:  P Martiat; C Mecucci; Y Nizet; M Stul; M Philippe; J J Cassiman; J L Michaux; H Van den Berghe; G Sokal
Journal:  Leukemia       Date:  1990-11       Impact factor: 11.528

3.  IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner.

Authors:  Seung-Hee Jo; Ruibao Ren
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

4.  An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myeloma.

Authors:  Nitin Roper; Daniel J DeAngelo; Frank Kuo; Paola Dal Cin; Irene Ghobrial; Jon C Aster
Journal:  Am J Hematol       Date:  2010-12       Impact factor: 10.047

5.  Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS).

Authors:  Susanne B Breitkopf; Min Yuan; German A Pihan; John M Asara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205
  5 in total
  2 in total

1.  Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.

Authors:  Subrahmanya D Vallabhapurapu; Sunil K Noothi; Derek A Pullum; Charles H Lawrie; Rachel Pallapati; Veena Potluri; Christian Kuntzen; Sohaib Khan; David R Plas; Robert Z Orlowski; Marta Chesi; W Michael Kuehl; P Leif Bergsagel; Michael Karin; Sivakumar Vallabhapurapu
Journal:  Nat Commun       Date:  2015-10-12       Impact factor: 14.919

2.  Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.

Authors:  Alex R Nanna; Xiuling Li; Even Walseng; Lee Pedzisa; Rebecca S Goydel; David Hymel; Terrence R Burke; William R Roush; Christoph Rader
Journal:  Nat Commun       Date:  2017-10-24       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.